Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List

Overview of attention for article published in BMC Health Services Research, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 287,200 followers.

RT @drabbyphilips: Sarpagandha/Indian Snake Root Shudnt B used in clinical trials: Kidney toxic https://t.co/qaqx9bZHbR Moderate-longter…

RT @drabbyphilips: Sarpagandha/Indian Snake Root Shudnt B used in clinical trials: Kidney toxic https://t.co/qaqx9bZHbR Moderate-longter…

RT @drabbyphilips: Sarpagandha/Indian Snake Root Shudnt B used in clinical trials: Kidney toxic https://t.co/qaqx9bZHbR Moderate-longter…

RT @drabbyphilips: Sarpagandha/Indian Snake Root Shudnt B used in clinical trials: Kidney toxic https://t.co/qaqx9bZHbR Moderate-longter…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.